Business Description
InMode Ltd
NAICS : 339112
SIC : 3845
ISIN : IL0011595993
Total Employee Number:
660Description
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 112.59 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.06 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 7.59 | |||||
Beneish M-Score | -2.26 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.1 | |||||
3-Year EBITDA Growth Rate | -17.3 | |||||
3-Year EPS without NRI Growth Rate | -12.9 | |||||
3-Year FCF Growth Rate | -15.1 | |||||
3-Year Book Growth Rate | 17.1 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 1.64 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 40.08 | |||||
9-Day RSI | 44.79 | |||||
14-Day RSI | 49.37 | |||||
3-1 Month Momentum % | 10.74 | |||||
6-1 Month Momentum % | 2.48 | |||||
12-1 Month Momentum % | 9.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 8.18 | |||||
Quick Ratio | 7.28 | |||||
Cash Ratio | 6.31 | |||||
Days Inventory | 296.02 | |||||
Days Sales Outstanding | 39.46 | |||||
Days Payable | 72.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 8.4 | |||||
Shareholder Yield % | 10.18 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 76.52 | |||||
Operating Margin % | 18.47 | |||||
Net Margin % | 20.69 | |||||
EBITDA Margin % | 18.66 | |||||
FCF Margin % | 22.03 | |||||
OCF Margin % | 22.31 | |||||
ROE % | 11.91 | |||||
ROA % | 10.53 | |||||
ROIC % | 30.92 | |||||
3-Year ROIIC % | -66.59 | |||||
ROC (Joel Greenblatt) % | 125.34 | |||||
ROCE % | 10.43 | |||||
Years of Profitability over Past 10-Year | 9 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 12.1 | |||||
Forward PE Ratio | 11.46 | |||||
PE Ratio without NRI | 10.78 | |||||
Price-to-Owner-Earnings | 13.34 | |||||
PEG Ratio | 3.48 | |||||
PS Ratio | 2.51 | |||||
PB Ratio | 1.36 | |||||
Price-to-Tangible-Book | 1.36 | |||||
Price-to-Free-Cash-Flow | 11.32 | |||||
Price-to-Operating-Cash-Flow | 11.18 | |||||
EV-to-EBIT | 5.2 | |||||
EV-to-Forward-EBIT | 3.23 | |||||
EV-to-EBITDA | 5.15 | |||||
EV-to-Forward-EBITDA | 3.21 | |||||
EV-to-Revenue | 0.96 | |||||
EV-to-Forward-Revenue | 0.99 | |||||
EV-to-FCF | 4.36 | |||||
Price-to-GF-Value | 0.77 | |||||
Price-to-Projected-FCF | 0.42 | |||||
Price-to-Graham-Number | 0.81 | |||||
| Price-to-Net-Current-Asset-Value | 1.53 | |||||
| Price-to-Net-Cash | 2.09 | |||||
Earnings Yield (Greenblatt) % | 19.23 | |||||
FCF Yield % | 9.64 | |||||
Forward Rate of Return (Yacktman) % | 1.87 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:INMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
InMode Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 374.625 | ||
| EPS (TTM) ($) | 1.23 | ||
| Beta | 1.6146 | ||
| 3-Year Sharpe Ratio | -0.76 | ||
| 3-Year Sortino Ratio | -0.87 | ||
| Volatility % | 20.53 | ||
| 14-Day RSI | 49.37 | ||
| 14-Day ATR ($) | 0.258409 | ||
| 20-Day SMA ($) | 15.191 | ||
| 12-1 Month Momentum % | 9.1 | ||
| 52-Week Range ($) | 12.72 - 16.74 | ||
| Shares Outstanding (Mil) | 57.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
InMode Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
InMode Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-02-10 08:30 | In 175 days | ||
| Annual report for 2026 | 2027-02-10 | In 174 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-10 | In 174 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-05 08:30 | In 78 days | ||
| Third quarter earnings results for 2026 | 2026-11-05 | In 77 days | ||
| Second quarter earnings results for 2026 | 2026-08-05 | 15.37 (+0.26%) | ||
| General meeting for 2025 | 2026-07-30 17:00 | 15.15 (-1.50%) | ||
| Jefferies Global Healthcare Conference | 2026-06-03 12:45 | 13.50 (-0.74%) | ||
| Barclays Virtual West Coast Bus Trip | 2026-05-20 | 13.97 (-0.71%) | ||
| First quarter earnings conference call for 2026 | 2026-05-06 08:30 | 14.40 (+0.35%) |
Show
Entries
InMode Ltd Frequently Asked Questions
What is InMode Ltd(INMD)'s stock price today?
The current price of INMD is $14.88. The 52 week high of INMD is $16.74 and 52 week low is $12.72.
When is next earnings date of InMode Ltd(INMD)?
The next earnings date of InMode Ltd(INMD) is 2026-11-05 Est..
Does InMode Ltd(INMD) pay dividends? If so, how much?
InMode Ltd(INMD) does not pay dividend.
Guru Commentaries on NAS:INMD
No articles.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers